CLASS II Drug recall · Reported 3 Jul 2019 · FDA Enforcement Report

ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites* recalled

Premier Pharmacy Labs is recalling ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites* in a Sterile SDV, distributed nationwide in the US. The recall was initiated on 18 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots remaining within expiry.
Quantity recalled824 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1413-2019
FDA event ID
83146
Recalling firm
Premier Pharmacy Labs, Weeki Wachee, FL
Classification
Class II
Status
Terminated
Recall initiated
18 Jun 2019
FDA classified
21 Jun 2019
Reported
3 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Undeclared Sulfites

Timeline

18 Jun 2019Recall initiated by company
21 Jun 2019Classified by FDA+3 days
3 Jul 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Product as listed by the FDA

ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites*, 1mL in a 5mL Sterile SDV, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-122-28, barcode 7 69623 12228 4.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites* in a Sterile SDV recalled?

Yes. Premier Pharmacy Labs recalled ChlorproMAZINE HCL INJ, 25mg/mL, *Contains Sulfites* in a Sterile SDV on 18 Jun 2019. The recall is Class II and its status is Terminated. Recall number D-1413-2019.

Why was it recalled?

Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Which lots are affected?

All lots remaining within expiry.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Premier Pharmacy Labs

All 24